PhaseBio Pharmaceuticals, Inc. (PHAS)
Free Cash Flow Growth
-25.96%
TTM · Period ending:
PHAS Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-25.96%period ending
Latest reported-25.96%period ending
PHAS TTM Free Cash Flow YoY % (-163.01% → -25.96%)
Year-over-year change
High-resolution chart · PNG
PHAS free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| -25.9617% | |
| -32.7806% | |
| 18.3708% | |
| 36.3437% | |
| 11.1256% | |
| 16.0198% | |
| -51.3266% | |
| -79.584% | |
| -85.3217% | |
| -140.8189% | |
| -136.1635% | |
| -174.8384% | |
| -163.0097% |